Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by American Health Packaging, priced at $0.4572 per EA under NDC 60687071925. Its NADAC has been published 125 times since Nov 15, 2023.
FDA first approved this application on Feb 28, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
Emtricitabine and tenofovir disoproxil fumarateStrength
200; 300 mg/1; mg/1
Manufacturer
American Health PackagingNDC
60687071925
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA212689FDA Approved
2/28/2020
TE Code
AB
On Market Since
10/23/2023
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 125 times since Nov 15, 2023, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4572 per EA |
|---|---|
| All-time high | $0.6149 (Dec 13, 2023) |
| All-time low | $0.4258 (May 22, 2024) |
| 52-week high | $0.5904 |
| 52-week low | $0.4572 |
| Median price | $0.5688 |
| Average price | $0.5466 |
| Largest weekly change | +37.3% (Jun 19, 2024) |
| Weeks tracked | 125 |
| Tracking since | Nov 15, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
-3.9%
1Y
-22.6%
3Y
N/A
5Y
N/A
All
-17.1%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by American Health Packaging, is $0.4572 per EA (NDC 60687071925), effective Apr 1, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 17.1%. It has been tracked across 125 weekly CMS publications since Nov 15, 2023.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since Nov 15, 2023, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.4258 (May 22, 2024) to a high of $0.6149 (Dec 13, 2023), with a median of $0.5688 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 60687071925) is labeled by American Health Packaging, and CMS classifies it as a generic product.